Roam - About the company
Roam is a series B company based in San Mateo (United States), founded in 2013 by Atul Suklikar, Alex Turkeltaub and Andrew Maas. It operates as a Machine learning platform for health data analysis. Roam has raised $22.4M in funding. The company has 262 active competitors, including 64 funded and 19 that have exited. Its top competitors include companies like BioAge Labs, Cellworks and Immuneering Corporation.
Company Details
Roam provides a machine learning platform for analyzing patient and provider pathway analysis. The platform uses comprehensive contextual data to assist biopharmaceutical and medical device companies with the predictive insights they need to make informed decisions as well as provides information on effective treatments. Its platform uses Real-World Evidence (RWE) to inform clinical development, patient outcomes, and risk-sharing agreements. Claims that it helps life sciences companies planning for a new product launch or working to improve the performance of an in-market treatment. Also, provides Roam Health Knowledge Graph for a unified mapping of internal company data, hospital data, and relevant external data to facilitate patient-level insights and drive improvements in care.
- Website
- www.roamanalytics.com
- Registered Address
- San Mateo, California
Key Metrics
Founded Year
2013
Location
San Mateo, United States
Stage
Series B
Total Funding
$22.4M in 4 rounds
Latest Funding Round
Ranked
26th among 262 active competitors
Employee Count
3 as on Mar 31, 2026
Legal entities associated with Roam
Roam is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ROAM ANALYTICS, INC. CIN: 455364192 , United States, Active | May 17, 2012 | - | 26 (As on Dec 31, 2019) | - |
Sign up to download Roam's company profile
Roam's funding and investors
Roam has raised a total funding of $22.4M over 4 rounds. Its first funding round was on Nov 20, 2013. Its latest funding round was a Series B round on May 03, 2016 for $*****. 1 investor participated in its latest round. Roam has 9 institutional investors.
Here is the list of recent funding rounds of Roam:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 03, 2016 | 9753356 | Series B | 1242825 | 2557894 | 8045579 | 8128167 |
Jul 01, 2015 | 6242334 | Series A | 5884179 | 2034651 | 1916163 | |
Dec 18, 2013 | 6325499 | Seed | 6028721 | 3371642 | 7840561 | 4984365 |
View details of Roam's funding rounds and investors
Roam's founders and board of directors
Founder? Claim ProfileHere are the details of Roam's key team members:
- Atul Suklikar: Co-Founder of Roam.
- Alex Turkeltaub: Co-Founder of Roam.
- Andrew Maas: Co-Founder of Roam.
View details of Roam's Founder profiles and Board Members
Roam's employee count trend
Roam has 3 employees as of Mar 26. Here is Roam's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Roam's Competitors and alternates
Top competitors of Roam include BioAge Labs, Cellworks and Immuneering Corporation. Here is the list of Top 10 competitors of Roam, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | BioAge Labs 2015, Vallejo (United States), Public | Provider of a bioinformatics platform for biomarkers and drug discovery | $294M | 64/100 | |
2nd | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 64/100 | |
3rd | Immuneering Corporation 2019, Cambridge (United States), Public | Provider of an AI-enabled bioinformatics platform for clinical solutions | $79M | 59/100 | |
4th | NantHealth 2007, El Segundo (United States), Public | Provider of bioinformatics platform to find treatment for cancer and other diseases | $608M | 58/100 | |
5th | Provider of semantic search platform for pharmaceutical and biotech research | $9.13M | 57/100 | ||
6th | Genedata 1997, Basel (Switzerland), Acquired | Software solutions for drug discovery, industrial biotechnology, and life science research | - | 57/100 | |
7th | Life Bit 2017, London (United Kingdom), Series B | AI and SaaS-based genomics analysis software for drug development | $70.9M | 55/100 | |
8th | Liquid Biosciences 2017, Aliso Viejo (United States), Series C | Provider of bio-analytics platform to identify the biological and behavioral truth driving patient outcomes | $40.1M | - | 53/100 |
9th | Biostate 2023, Houston (United States), Series A | Developer of generative AI based RNAstate research platform to predict future omics states | $16M | 53/100 | |
10th | Provider of bioinformatic platforms for health management and drug development | $366M | 53/100 | ||
26th | Roam 2013, San Mateo (United States), Series B | Machine learning platform for health data analysis | $22.4M | 45/100 |
Looking for more details on Roam's competitors? Click here to see the top ones
Roam's Investments and acquisitions
Roam has made no investments or acquisitions yet.
Reports related to Roam
Here is the latest report on Roam's sector:
News related to Roam
•
Parexel Completes Purchase of Roam Analytics’ Natural Language Processing CapabilityGlobeNewswire•Sep 22, 2020•Parexel, Roam, Roam Analytics
•
Worldwide Healthcare AI - Market Market Size and Forecasts (2017 - 2022)PR Newswire•Nov 15, 2017•Roam, 3Scan, CloudMedx, CureMetrix
Are you a Founder ?
FAQs about Roam
Explore our recently published companies
- Tempo - San Francisco based, 2017 founded, Series A company
- icesolar.co - Seed company
- PayCentral.ai - Gandhinagar based, 2025 founded, Unfunded company
- Fan Milk Nigeria - 1963 founded, Public company
- uam.refer.ne - Funding Raised company
- cssd.ac.uk - Funding Raised company